Bazarbashi, S.; AlManea, H.; Aljubran, A.; Alzahrani, A.; Alqahtani, A.; Almugbel, F.; Rauf, M.S.; Ghebeh, H.
Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival. Cancers 2025, 17, 3963.
https://doi.org/10.3390/cancers17243963
AMA Style
Bazarbashi S, AlManea H, Aljubran A, Alzahrani A, Alqahtani A, Almugbel F, Rauf MS, Ghebeh H.
Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival. Cancers. 2025; 17(24):3963.
https://doi.org/10.3390/cancers17243963
Chicago/Turabian Style
Bazarbashi, Shouki, Hadeel AlManea, Ali Aljubran, Ahmed Alzahrani, Ali Alqahtani, Fahad Almugbel, Muhammad Shahzad Rauf, and Hazem Ghebeh.
2025. "Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival" Cancers 17, no. 24: 3963.
https://doi.org/10.3390/cancers17243963
APA Style
Bazarbashi, S., AlManea, H., Aljubran, A., Alzahrani, A., Alqahtani, A., Almugbel, F., Rauf, M. S., & Ghebeh, H.
(2025). Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Infusional Gemcitabine: Immune Cell Infiltration Analysis and Updated Survival. Cancers, 17(24), 3963.
https://doi.org/10.3390/cancers17243963
